Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2008
12/04/2008US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection
12/04/2008US20080299139 Mammalian cytokines; related reagents and methods
12/04/2008US20080299138 Toll-Like Receptor 3 Modulators and Uses Thereof
12/04/2008US20080299135 Methods and compositions for nerve regeneration
12/04/2008US20080299125 Genetic basis of treatment response in depression patients
12/04/2008US20080299121 Multivalent recombinant antibodies for treating HRV infections
12/04/2008US20080299119 Polypeptides homologous to vegf and bmp1
12/04/2008US20080299116 Vascular Endothelial Cell Growth Factor Antagonists and Uses Thereof
12/04/2008US20080299113 Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
12/04/2008US20080299109 Mechanism of astricyte-neuron signaling
12/04/2008US20080299108 Peptides for Diagnostic and Therapeutic Methods for Celiac Sprue
12/04/2008US20080299107 Combinations of human proteins to enhance viability of transplanted stem cells and progenitor cells
12/04/2008US20080299106 Combinations of human proteins to enhance in vivo viability of stem cells and progenitor cells
12/04/2008US20080299105 Inhibition of Feline Calicivirus
12/04/2008US20080299104 Methods for detecting agents involved in neuronal apoptosis and compositions thereof
12/04/2008US20080299103 Well Preserved Aqueous Organic Compositions
12/04/2008US20080299102 Novel BACE proteins, nucleic acid molecules therefor, novel crystal structure of novel BACE proteins, and methods for making and using
12/04/2008US20080299101 Cancer Treatment Resistance and Agents Modulating Such Resistance
12/04/2008US20080299093 Premixed biological hydraulic cement paste composition and using the same
12/04/2008US20080299089 Endogeneous repair factor production promoters
12/04/2008US20080299088 Uses of Notch Receptors, Notch Ligands, and Notch Modulators in Methods Related to Metabolic Diseases
12/04/2008US20080299083 Adenoviral vectors having a protein IX deletion
12/04/2008US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene
12/04/2008US20080299080 Thiophene analogues for the treatment or prevention of flavivirus infections
12/04/2008US20080299079 Absorption Enhancers for Drug Administration
12/04/2008US20080299078 Tumor associated amino acids and uses therefor
12/04/2008US20080299077 Isolation and growth of stem cells from hemangiomas
12/04/2008US20080299076 Compunds and compositions that cause non-apoptotic cell death and uses thereof
12/04/2008US20080299075 a mixture of viricides such as dimethyl(4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl((1S)-2-methyl-1,1-propanediyl)imino((2S)-1-oxo-1,2-propanediyl)))biscarbamate, carriers and one or two additional antiviral drugs, used for the treatment of viral infections
12/04/2008US20080299074 A-beta immunogenic peptide carrier conjugates and methods of producing same
12/04/2008US20080299073 Method For Treatment Or Prophylaxis Of An Infection Using Either An Antibody Which Binds To IL-9 Or An Agent Which Stimulates Production Of Autoantibodies To Interleukin-9
12/04/2008US20080299072 Chemokine Antagonists
12/04/2008US20080299071 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
12/04/2008US20080299045 Composition for Prevention, Treatment, and Diagnosis of Chronic Obstructive Pulmonary Disease (Copd)
12/04/2008US20080299040 Diagnosis and therapy of cancer and noncancerous diseases; complexes with radioactive material
12/04/2008US20080299039 Aprotinin Polypeptides for Transporting a Compound Across the Blood-Brain Barrier
12/04/2008DE102007025107A1 Arzneimittel zur Behandlung von Fertilitäts- und Schwangerschaftsstörungen und immunologisch-bedingten Erkrankungen und Transplantationen zur Anwendung in der Tiermedizin, insbesondere bei Pferden sowie Verfahren zur Herstellung Medicines used to treat fertility and pregnancy disorders and immunologically-related disorders and transplantation for use in veterinary medicine, particularly in horses and methods of making
12/04/2008DE102007024852A1 Strongly enriching the amino acids and/or oligopeptides based on sweet whey powder, which is dissolved in water, comprises converting sugar to lactic acid and proteins to oligopeptides and amino acids using protease or lactic acid bacterium
12/04/2008CA2692652A1 Hpv epitopes targeted by t cells infiltrating cervical malignancies for use in vaccines
12/04/2008CA2689066A1 Reconstituted surfactants having improved properties
12/04/2008CA2688587A1 Nucleic acid and amino acid sequences, and vaccine to control sea lice infestations in fish
12/04/2008CA2688543A1 Vegf-d mutants and their use
12/04/2008CA2688417A1 Calcium channel proteins and uses thereof
12/04/2008CA2688344A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008CA2688318A1 Whitening agent
12/04/2008CA2688194A1 Antiviral drugs for treatment or prevention of dengue infection
12/04/2008CA2688061A1 Multicistronic vectors and methods for their design
12/04/2008CA2687990A1 Cross-linked collagen and uses thereof
12/04/2008CA2687604A1 Methods for preparing factor x, activated factor x, inactivated factor x and inactivated factor xa, and pharmaceutical compositions comprising same
12/04/2008CA2687377A1 Immunoglobulin fusion proteins
12/04/2008CA2686803A1 Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders
12/04/2008CA2686642A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin
12/04/2008CA2686637A1 Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin in solid form
12/03/2008EP1998266A2 Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2008EP1998177A2 Compositions and methods for diagnosing and treating colon cancers
12/03/2008EP1997897A1 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
12/03/2008EP1997895A1 Family of nucleic sequences and deduced protein sequences having human endogenous retroviral patterns, their flanking sequences and their applications
12/03/2008EP1997893A1 Compositions containing an OX-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/03/2008EP1997891A1 Generation and selection of recombinant varied binding proteins
12/03/2008EP1997890A1 Chinese hamster apoptosis-related genes
12/03/2008EP1997829A1 Albumin fusion proteins
12/03/2008EP1997828A2 Stabilized alpha helical peptides from BCL-2 and uses thereof
12/03/2008EP1997827A1 Compounds analogous to growth hormone peptide secretagogues and preparations containing them
12/03/2008EP1997826A2 Synthetic ligands for immunoglobulins and pharmaceutical compositions containing them
12/03/2008EP1997823A1 Boronic ester and acid compounds, synthesis and uses
12/03/2008EP1997514A1 High avidity polyvalent and polyspecific reagents
12/03/2008EP1997513A1 Photodynamic therapy for treating conditions of the eye
12/03/2008EP1997512A2 Methods for treating TWEAK-related conditions
12/03/2008EP1997510A1 Non-neurotoxic plasminogen-activating factors for treating strokes
12/03/2008EP1997509A1 Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin
12/03/2008EP1997508A2 S-adenosyl homocysteinase (SAHH) as a therapeutic agent for cancer
12/03/2008EP1997507A2 Treatment of annulus fibrosis defects
12/03/2008EP1997506A1 Use of ck2 inhibitor for the treatment and chemosensibilization of refractory tumors to anticancer drugs
12/03/2008EP1997505A1 Erythropoietin solution preparation
12/03/2008EP1997504A1 Novel antithrombotic agent
12/03/2008EP1997503A2 Treatment of melanoma with alpha thymosin peptides
12/03/2008EP1997502A1 Reconstituted surfactants having improved properties
12/03/2008EP1997498A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/03/2008EP1997483A1 Rh-epo nasal formulations with low sialic acid concentration for the treatment of diseases of the central nervous system
12/03/2008EP1996715A1 Bacterial antigens and uses thereof
12/03/2008EP1996701A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2
12/03/2008EP1996700A1 Cancerous disease modifying antibody 141205-05
12/03/2008EP1996615A2 Broad spectrum antiviral compositions
12/03/2008EP1996612A1 Compositions for treatment of cancer
12/03/2008EP1996609A2 Method of preparing glycopeptides
12/03/2008EP1996608A1 Cyclopeptide with anti-cancer activity derived from collagen type iv
12/03/2008EP1996606A1 Tropolone- and hydroxybenzene-substituted oligopeptides for depigmentation
12/03/2008EP1996292A1 Use of peptides for the control of radiation injury
12/03/2008EP1996233A2 Combinations comprising a histone deacetylase inhibiting agent and a nuclear hormone receptor ligand for treating cardiovascular conditions
12/03/2008EP1996232A2 CANCER TREATMENT COMBINING LYMPHODEPLETING AGENT WITH CTLs AND CYTOKINES
12/03/2008EP1996226A2 Methods, compositions and devices for maintaining chemical balance of chlorinated water
12/03/2008EP1996225A1 Method and composition for protection against radiation
12/03/2008EP1996224A1 Mixtures of amylin and insulin
12/03/2008EP1996223A1 Acylated single chain insulin
12/03/2008EP1996222A2 Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
12/03/2008EP1996221A2 Methods for reducing protein aggregation
12/03/2008EP1996220A2 Unstructured recombinant polymers and uses thereof
12/03/2008EP1996219A2 Treatment of ischemic disease using thrombopoietin
12/03/2008EP1996218A2 Methods and compositions for the treatment of gastrointestinal disorders
12/03/2008EP1996217A2 Novel antibiotic compositions